Potential of evening primrose, borage, black currant, and fungal oils in human health

Annals of Nutrition and Metabolism

Volumn 45, Issue 2, 2001, Pages 47-57

  Barre, D Edward ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLACK CURRANT EXTRACT; BORAGE EXTRACT; FUNGAL OIL EXTRACT; PRIMROSE OIL; UNCLASSIFIED DRUG;

BLOOD PRESSURE REGULATION; DIET SUPPLEMENTATION; HUMAN; LIPID BLOOD LEVEL; LIPID COMPOSITION; NUTRITION; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; THROMBOCYTE AGGREGATION;

ALPHA-LINOLENIC ACID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; ARTHRITIS; BLOOD PRESSURE; CORONARY ARTERIOSCLEROSIS; DERMATITIS; DERMATOLOGIC AGENTS; FATTY ACIDS, ESSENTIAL; GAMMA-LINOLENIC ACID; HUMANS; HYPERTENSION; LINOLEIC ACIDS; LIPIDS; PLANT OILS; PLATELET AGGREGATION; TREATMENT OUTCOME;

EID: 0035009295     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046706     Document Type: Review

References (119)

1. Engler MM: Comparative study of diets enriched with evening primrose, black currant, borage or fungal oils on blood pressure and pressor responses in spontaneously hypertensive rats. Prostaglandins Leukot Essent Fatty Acids 1993;49:809-814.
2. Fan Y-Y, Chapkin RS, Ramos KS: Dietary lipid source alters murinc macrophage/vascular smooth muscle cell interactions in vitro. J Nutr 1996;126:2083-2088.
3. 2 inhibition. Prostaglandins Leukot Essent Fatty Acids 1996;55:159-165.
4. Horrobin DF: Fatty acid metabolism in health and disease: the role of Δ6-desaturase. Am J Clin Nutr 1993;57(suppl):732S-737S.
5. Corrigan FM, Horrobin DF, Skinner ER, Besson JAO, Cooper MB: Abnormal content of n-6 and n-3 unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimers' disease patients and its relationship to acetyl CoA content. Int J Biochcm Cell Biol 1998;30:197-207.
6. Doris AB, Wahle K, MacDonald A, Morris S, Coffey I, Muir W, Blackwood D: Red cell membrane fatty acids, cytosolic phospholipase-A2 and schizophrenia. Schizophrenia 1998;31: 185-196.
7. Manku MS, Horrobin DF, Morse NL, Wright S, Burton JL: Essential fatty acids in the plasma phospholipids of patients with ectopic eczema. Br J Dermatol 1984;110:643-648.
8. Strannegard IL, Svennerholm L, Strannegaard O: Essential fatty acids in serum lecithin of children with atopic dermatitis and in umbilical corn serum of infants with high or low IgE levels. Int Arch Allergy Applied Immunol 1987;82:422-423.
9. Brush MG, Watson SJ, Horrobin DF, Manku MS: Abnormal essential fatty acid levels in plasma of women with premenstrual syndrome. Am J Obstet Gynecol 1984;150:363-366.
10. Manku MS, Morse-Fisher N, Horrobin DF: Changes in human plasma essential fatty acid levels as a result of administration of linoleic acid. Eur J Clin Nutr 1988;42:55-60.
11. Cunnane SC: The Canadian Society for Nutritional Sciences 1995 Young Scientist Award Lecture. Recent studies on the synthesis, β-oxidation. and deficiency on linoleate and alpha-linolenate: Are essential fatty acids more aptly named indispensable or conditionally dispensable fatty acids? Can J Physiol Pharmacol 1996;74:629-639.
12. Kinsella JE: α-Linolenic acid: Functions and effects on linoleic acid metabolism and eicosanoid-mediated reactions. Adv Food Nut Res 1991;35:1-184.
13. Lucas A, Morley R, Cole TJ, Lister G, Leeson-Payne C: Breast milk and subsequent intelligence quotient in children born pre-term. Lancet 1992;339:261-264.
14. Fiocchi A, Sala M, Signorini P, Banderall G, Agostoni C, Riva E: The efficacy and safety of γ-linolenic acid in the treatment of infantile atopic dermatitis. J Int Med Res 1994;22:24-32.
15. Biagi PL, Bordoni A, Hrelia S, Celadon M, Ricci GP, Cannella V, Patrizi A, Specchia F, Masi M: The effect of gamma-linolenic acid on clinical status, red cell fatty acid composition and membrane microviscosity in infants with atopic dermatitis. Drugs Exp Clin Res 1994;20:77-84.
16. Bahmer FA: ADASI Score: Atopic dermatitis area and severity index. Acta Derm Venereol Suppl (Stockh) 1992;176:32-33.
17. Tollesson A, Frithz A: Trans-epidermal water loss and water content in the stratum corneum in infantile seborrhoeic dermatitis. Acta Derm Venereol (Stockh) 1993;73:18-20.
18. Tollesson A, Frithz A: Borage oil, an effective new treatment for infantile sebborrhoeic dermatitis . Br J Dermatol 1993;129:95.
19. Hederos C-A, Berg A: Epogam evening primrose oil treatment in atopic dermatitis and asthma. Arch Dis Child 1996;75:494-497.
20. Ziboh VA: The significance of polyunsaturated fatty acids in cutaneous biology. Lipids 1996: 31(suppl):S249-S253.
21. 2 in atopic dermatitis. Br J Dermatol 1997;136:337-340.
22. Lehmann B, Hubner C, Jacobi H, Kampf A, Wozel G: Effects of dietary γ-linolenic acid enriched evening primrose seed oil on the 5-lipoxygenase pathway of neutrophil leukocytes in patients with atopic dermatitis. J Dermatol Treat 1995;6:211-218.
23. Whittaker DK, Cilliers J, deBeer C: Evening primrose oil (Epogam) in the treatment of chronic hand dermatitis: Disappointing therapeutic results. Dermatology 1996;193:115-120.
24. Berth-Jones J, Graham-Brown RAC: Placebo controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet 1993; 341:1557-1560.
25. Horrobin DF, Morse PF: Evening primrose and atopie eczema. Lancet 1995;345:260-261.
26. Wright S, Burton JL: Oral evening-primrose-seed oil improves atopic eczema. Lancet 1982; ii:1120-1122.
27. Bamford JTM, Gibson RW, Renier CM: Atopic eczema unresponsive to evening primrose oil (linoleic and γ-linolenic). J Am Acad Dermatol 1985;13:959-965.
28. Biagi P, Bordoni A, Masi M, Ricci G, Fanelli C, Patrizi Ceccolini E: A long-term study on the use of evening primrose oil (Efamol) in atopic children. Drugs Exp Clin Res 1988;14:285-290.
29. Morse PF, Horrobin DF, Manku MS, Stewart JCM, Allen R, Littlewood S, Wright S, Burton J, Gould DJ, Holt PJ, Jansen CT, Mattila L, Meigel W, Dettke TH, Wexler D, Guenther L, Bordoni A, Patrizi A: Meta-analysis of placebo controlled studies in the efficacy of Epogram in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response. Br J Dermatol 1989;121: 75-90.
30. Schalin-Karrila M, Mattila L, Jansen CT, Uotila P: Evening primrose oil in the treatment of atopic eczema: Effect of clinical status, plasma phospholipid fatty acids and circulating prostaglandins. Br J Dermatol 1987;117:11-19.
31. Bordoni A, Biagi PL, Masi M, Ricci G, Fanelli C, Patrizi A, Ceccolini E: Evening primrose oil (Efamol) in the treatment of children with atopic eczema. Drugs Exp Clin Res 1987;14: 291-297.
32. Stewart JCM, Morse PF, Moss M, Horrobin DF, Burton JL, Douglas WS, Gould DJ, Grattan CEH, Hindson TC, Anderson J, Jansen CT, Kennedy CTC, Lindskov R, Strong AMM, Wright S: Treatment of severe and moderately severe atopic dermatitis with evening primrose oil (Epogram): A multi-centre study. J Nutr Med 1991;2:9-15.
33. Humphreys F, Symons JA, Brown HK, Duff GW, Hunter JAA: The effects of gamolenic acid on adult atopic eczema and premenstrual exacerbation of eczema. Eur J Dermatol 1994; 4:598-603.
34. Anstey A, Quigley M, Wilkinson JD: Topical evening primrose oil as a treatment for atopic eczema. J Dermatol Res 1990;1:199-201.
35. Andreassi M, Forleo P, Di Lorio A, Masci S, Abate G, Amerio P: Efficacy of γ-linolenic acid in the treatment of patients with atopic dermatitis. J Int Med Res 1997;25:266-274.
36. Henz BM, Jablonska S, van de Kerkhof PCM, Stingl G, Blascyk M, Vandervalk PGM, Veenhuizen R, Muggli R, Raederstorff D: Double-blind, multicentre analysis of the efficacy of borage oil in patients with atopic eczema. Br J Dermatol 1999;140:685-688.
37. Belch JJF, Ansell D, Madhok R, O'Dowd A, Sturrock RD: Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: A double blind placebo controlled study. Ann Rheum Dis 1988;47:96-104.
38. Jantti J, Seppala E, Vapaatalo H, Isomaki H: Evening primrose oil and olive oil in treatment of rheumatoid arthritis. Clin Rheumatol 1989; 8:238-244.
39. Brzeski M, Madhok R, Capell HA: Evening primrose oil in patients with rheumatoid arthritis and side-effects of non-steroidal antiinflammatory drugs. Br J Rheumatol 1991;30: 370-372.
40. Pullman-Mooar S, Ohligher D, Laposata M, Zurier RB: Effect of gamma-linolenic acid on human leucocyte function. Clin Res 1988;36: 536A.
41. Pullman-Mooar S, Laposata M, Lem D, Holman RT, Leventhal LJ, DeMarco D, Zurier RB: Alteration of the cellular fatty acid profile of eicosanoids in human monocytes by gamma-linolenic acid. Arthritis Rheum 1990;33:1526-1533.
42. Leventhal LJ, Boyce EG, Zurier RB: Treatment of rheumatoid arthritis with gamma-linolenic acid. Ann Intern Med 1993;119:867-873.
43. Zurier RB, Rossetti RG, Jacobsen E, DeMarco DM, Liu NY, Temming JE, White BM, LaPosata ML: Gamma-linolenic acid treatment of rheumatoid arthritis. A randomized placebo-controlled study. Arthritis Rheum 1996;39: 1808-1817.
44. Watson J, Byars ML, McGill P, Kelman AW: Cytokine and prostaglandin production by monocytes of volunteers and rheumatoid arthritis patients treated supplements of black-currant seed oil. Br J Rheumatol 1993;32: 1055-1058.
45. Dinarello CA: Anti-cytokine strategies. Eur Cytokine Netw 1992;3:7-17.
46. Ziboh VA, Fletcher MP: Dose-response effects of dietary γ-linolenic acid enriched oils on human polymorphonuclear-neutrophil biosynthesis of leukotriene biosynthesis. Am J Clin Nutr 1992;55:39-45.
47. Corbett R, Meagher JBA, Leonard BE: The effect of acute alcohol intoxication on psychometric testing and 5-HT-induced platelet aggregation in normal subjects; modulatory role of evening primrose oil. Hum Psychopharm 1991;6:253-256.
48. 2 formation. Nutr Res 1993;13:739-751.
49. McGregor L, Smith AD, Sidey M, Belin J, Zikha KJ, McGregor JL: Effects of dietary linoleic and gamma linolenic acid on platelets of patients with multiple sclerosis. Acta Neurol Scand 1989;80:23-27.
50. Vericel E, Lagarde M, Mendy F, Courpron P, Dechavanne M: Comparative effects of linoleic acid and gamma-linolenic acid intake on plasma lipids and platelet phospholipids in elderly people. Nutr Res 1987;7:569-580.
51. Boberg M, Vessby B, Selenius I: Effects of dietary supplementation with n-6 and n-3 long chain polyunsaturated fatty acids on serum lipoproteins and platelet function in hypertriglyceridaemic patients. Acta Med Scand 1986; 220:153-160.
52. Darcet P, Dris F, Mendy F, Delhaye N: Exploration du métabolism des acides gras des lipides totaux plasmatiques et de l'agrégation plaquettaire d'une population d'hommes âgés à l'aide d'une alimentation enrichie en acide γ-linolénique. Ann Nutr Aliment 1980;34:277-290.
53. Guiverneau M, Meza N, Barrja P, Roman O: Clinical and experimental study on the long terms effect of dietary gamma-linolenic acid on plasma lipids, platelet aggregation, thromboxane formation and prostacyclin production. Prostaglandins Leukot Esscnt Fatty Acids 1994;51:311-316.
54. Mills DE, Mah M, Ward PP, Morris BL, Floras JS: The effects of stress and dietary n-6 and n-3 rich oils on platelet aggregation in man. Proc ISF/JAOCS World Congress 1989, vol 1, pp 281-287.
55. Bard JM, Luc G, Jude B, Bordet JC, Lacroix B, Bonte JP, Parra HJ, Duriez P: A therapeutic dosage (3 g/day) of borage oil supplementation has no effect on platelet aggregation in healthy volunteers. Fundam Clin Pharmacol 1997;11: 143-144.
56. Barre DE, Holub BJ: The effect of borage oil consumption on the composition of individual phospholipids in human platelets. Lipids 1992; 27:315-320.
57. McKean ML, Silver JB, Silver MJ: Formation of lysocholine-containing phospholipids by human platelets in response to thrombin. J Biol Chem 1981;256:1522-1524.
58. Rodgers RPC, Levin J: A critical re-appraisal of the bleeding time. Semin Thromb Hemost 1990;16:1-20.
59. Nakahara T, Yokochi T, Kamisaka Y, Yamaoka M, Suzuki O, Sato M, Okazaki S, Ohshima N: Inhibitory effects of mold oil including gamma-linolenate on platelet thrombus formation in mesenteric microvessels of the rat. Thromb Res 1990;57:371-381.
60. Chaintreuil J, Monnier L, Collete C, Crastes de Paulet P, Orsetti A, Spielmann D, Mendy F, Crastes de Paulet A: Effects of dietary γ-linolenate supplementation on serum lipids and platelet function in insulin dependent diabetic patients. Hum Nutr Clin Nutr 1984;38C:121-130.
61. Jantti J, Nikkari T, Solakivi T, Vapaatalo H, Isomaki H: Evening primrose oil in rheumatoid arthritis: Changes in serum lipids and fatty acids. Ann Rheum Dis 1989;48:124-127.
62. Abraham RD, Riermersma RA, Elton RA, Macintyre C, Oliver MF: Effects of safflower oil and evening primrose oil in men with a low dihomo-γ-linolenic acid. Atherosclerosis 1990; 81:199-208.
63. Richard J-L, Martin C, Maille M, Mendy F, Delplanquc B, Jacotot B: Effects of dietary intake of gamma-linolenic acid on blood lipids and phospholipid fatty acids in healthy human subjects. J Clin Biochem Nutr 1990;8:75-84.
64. Vikkari J, Lehtonen A: Effect of primrose oil on serum lipids and blood pressure in hyperlidemic subjects. Int J Clin Pharmacol Ther Toxicol 1986;24:668-670.
65. Ishikawa T, Fujiyama Y, Igarashi O, Morino M, Tada N, Kagami A, Sakamoto T, Nagano M, Nakamura H: Effects of gammalinolenic acid on plasma lipoprotcins and apoproteins. Atherosclerosis 1989;75:95-104.
66. Horrobin DF, Manku MS: How do polyunsaturated acids lower plasma cholesterol levels. Lipids 1983;18:558-562.
67. Barre DE, Holub BJ: The effect of borage oil consumption on human plasma lipid levels and the choline-containing phospholipids and cholesterol ester composition of high density lipoprotein. Nutr Res 1993;12:1181-1194.
68. Dyerberg J, Bang HO, Hjome N: Fatty acid composition of the plasma lipids of Greenland Eskimoes. Am J Clin Nutr 1975;28:958-966.
69. Seri S, D'Allessandro A, Acitelli S, Giammaria U, Cocchi M, Noble RC: Effect of dietary supplementation by alternative oils on blood lipid levels in hemodialysed patients. Med Sci Res 1993;21:315-316.
70. Spielmann D, Traitler H, Crozier G, Fleith M, Bracco U, Finot PA, Berger M, Holman RT: Biochemical and bioclinical aspects of black-currant seed oil ω-3 ω-6 balanced oil; in Galli C, Simopoulos AP (eds): Dietary ω-3 and ω-6 Fatty Acids. New York, Plenum Press, 1989, pp 309-321.
71. Agostini C, Riva E, Biascucci G, Luotti D, Bruzzese MG, Marangoni F, Giovannini M: The effects of n-3 and n-6 polyunsaturated fatty acids on plasma lipids and fatty acids of treated phenylketonuric children. Prostaglandins Leukot Essent Fatty Acids 1995;53:401-404.
72. Innis SM, Hansen JW: Plasma fatty acid responses, metabolic effects and safety of microalgal and fungal oils rich in arachidonic and docosahexaenoic acids in healthy adults. Am J Clin Nutr 1996;64:159-167.
73. Takada R, Saitoh M, Mori T: Dietary -γ-linolenic acid-enriched oil reduces body fat content and induces liver enzyme activities relating to β-fatty acid oxidation in rats. J Nutr 1994;124: 469-474.
74. Sugano M, Ishida T, Yoshida K, Tanaka K, Niwa M, Arima M, Morita A. Effects of mold oil containing γ-linolenic acid on blood cholesterol and eicosanoid levels in rats. Agric Biol Chem 1986;50:2483-2491.
75. Bergstrom JD: Is squalene synthase a good target for cholesterol lowering therapy? Studies with the zaragozic acids (abstract). Drugs Affecting Lipid Metabolism Conference 1995, Houston, p 6.
76. Harada T, Hasumi K, Endo A: Induction of low density lipoprotein catabolism in Hep G2 cells by a fungal sesquiterpene ester, FR111142. Biochem Biophys Res Commun 1998;251:830-834.
77. Jialal I, Norkus EP, Cristol L, Grundy SM: β-Carotene inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1991;1086:134-138.
78. Cerda-Olmeda E, Avalos J: Oleaginous fungi: Carotene-rich oil from phycomyces. Prog Lipid Res 1994;33:185-192.
79. Parthasarathy S: Novel atherogenic oxidative modification of low density lipoprotein. Diabetes Metab Rev 1991;7:163-171.
80. Phylactos AC, Harbige LS, Crawford MA: Essential fatty acids alter the activity of manganese-superoxide dismutase in rat heart. Lipids 1994;29:111-115.
81. Fievet P, Tribout P, Castier B, Dieval J, Capiuod JC, Delobel J, Coevoet B, Fournier A: Effects of evening primrose oil on platelet functions during pregnancy in patients with high risk of toxemia. Kidney Int 1985;28:234.
82. Mills DE, Prakachin KM, Harvey KA, Ward RP: Alteration of baroflex control of forearm vascular resistance by dietary fatty acids. Am J Physiol 1990;259:R1164-R1171.
83. Mills DE, Prakachin KM, Harvey KA, Ward RP: Dietary fatty acid supplementation alters stress reactivity and performance in man. J Hum Hypertens 1989;3:111-116.
84. Stroop JR: Studies of interference in serial verbal reactions. J Exp Psycliol 1935;18:643-662.
85. Deferne J-L, Leeds AR: Resting blood pressure and cardiovascular reactivity to mental arithmetic in mild hypertensive males supplemented with blackcurrant seed oil. J Hum Hypertens 1996;10:531-537.
86. Fisher BAC, Harbige LS: Effect of omega-6 lipid rich borage feeding on immune function in healthy volunteers. Biochem Soc Trans 1997; 25:3435.
87. Wu D, Meydani M, Leka LS, Nightingale Z, Handelman GJ, Blumberg JB, Meydani SM: Effect of dietary supplementation with black current seed oil on the immune response of healthy response of healthy elderly subjects. Am J Clin Nutr 1999;70:536-543.
88. Horrobin DF: Essential fatty acids in the management of impaired nerve function in diabetes. Diabetes 1997;46(suppl 2):S90-93.
89. Horrobin DF: The use of gamma-linolenic acid in diabetic neuropathy. Agents Actions Suppl 1992;37:120-144.
90. Wolever TMS: Comments on the treatment of diabetic neuropathy with γ-linolenic acid by the γ-linolenic multicenter trial group. Diabetes Care 1993;16:1309.
91. Keen H, Payan J, Allawi J, Walker J, Jamal GA, Weir Al, Henderson LM, Bissessar EA, Watkins PJ, Sampson PJ, Sampson M, Gale EAM, Scarpello J, Boddie HG, Hardy KJ, Thomas PK, Misra P, Halonen J-P: Treatment of diabetic neuropathy with γ-linolenic acid. Diabetes Care 1993;16:8-15.
92. Horrobin DF: The effects of gamma-linolenic acid on breast pain and diabetic neuropathy: possible non-eicosanoid mechanisms. Prostaglandins Leukot Essent Fatty Acids 1993;48: 101-104.
93. Fedele D, Guigliano D: Peripheral diabetic neuropathy. Current recommendations and future prospects. Drugs 1997;54:414-421.
94. Jamal GA: The use of gamma linolenic acid in the prevention and treatment of diabetic neuropathy. Diabetic-Med 1994;11:145-149.
95. Kuruvilla R, Peterson RG, Kincaid JC, Eichberg J: Evening primrose oil treatment corrects reduced conduction velocity but not depletion of arachidonic acid in nerve from streplozotocin-induced diabetic rats. Prostaglandins Leukot Essent Fatty Acids 1998;59:195-202.
96. + ATPase activity and membrane fatty acid composition in sciatic nerve of diabetic rats. J Nutr Biochem 1999;10:411-420.
97. Head RJ, McLennan PL, Raederstorff D, Muggli R, Burnard SL, McMurchie EJ: Prevention of nerve conduction deficit in diabetic rats by polyunsaturated fatty acids. Am J Clin Nutr 2000:71(suppl):386S-392S.
98. Cameron NE, Cotter MA: Comparison of the effects of ascorbyl γ-linolenic acid and γ-linolenic acid in the correction of neurovascular deficits in diabetic rats. Diabetologica 1996; 39:1047-1054.
99. Cameron NE, Cotter MA, Horrobin DH, Tritschler HJ: Effects of α-lipoic acid on neurovascular function in diabetic rats: Interaction with essential fatty acids. Diabetologica 1998;41:390-399.
100. Peth JA, Kinnick TR, Youngblood EB, Tritschler HJ, Henriksen EJ: Effects of a unique conjugate of α-lipoic acid and γ-linolenic acid on insulin secretion in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 2000;278:R453-459.
101. Hounsom LM, Horrobin DF, Tritschler H, Corder R, Tomlinson DR: A lipoic acid-gamma-linolenic acid conjugate if effective against multiple indices of experimental diabetic neuropathy. Diabetologica 1998;41: 839-843.
102. Cameron NE, Cotter MA: Interaction between oxidative stress and γ-linolenic acid in impaired neurovascular function of diabetic rats. Am J Physiol 1996;271:E471-E476.
103. Reljanovic M, Reichel G, Rett K, Lobisch M, Schuette K, Moller W, Tritschler H-J, Mehrnet H, Aladin II Study Group: Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (α-lipoic acid): A two year multicenter randomized double-blind placebo-controlled trial (Aladin II). Free Radic Res 1999; 31:171-179.
104. Vinik AI: Diabetic neuropathy: Pathogenesis and therapy. Am J Med 1999;107:17S-26S.
105. Greenfield SM, Green AT, Geare JP, Jenkins AP, Punchard NA, Ainley CC, Thompson RPH: A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis. Aliment Pharmacol Ther 1993;7:159-166.
106. Wagner W, Nootbaar-Wagner U: Prophylactic treatment of migraine with gamma-linolenic acid and alpha-linolenic acids. Cephalagia 1997;17:127-130.
107. Venuta A, Spano C, Laudizi L, Bettelli F, Beverelli A, Turchetto E: Essential fatty acids: The effects of dietary supplementation among children with recurrent respiratory infections. J Intern Med Res 1996;24:325-330.
108. Budeiri D, Li Wan Po A, Dornan JC: Is evening primrose oil of value in the treatment of premenstrual syndrome? Control Clin Trials 1996;17:60-68.
109. Khoo SK, Munro C, Battislutta D: Evening primrose oil and the treatment of premenstrual syndrome. Med J Aust 1990;153:189-192.
110. Horrobin DF: The role of essential fatty acids and prostaglandins in the premenstrual syndrome. J Reprod Med 1983;28:465-469.
111. van der Merwe CF, Booyens J, Joubert HF, van der Merwe CA: The effect of gamma-linolenic acid, an in vitro cytostatic substance contained in evening primrose oil, on primary liver cancer. A double blind placebo-controlled trial. Prostaglandins Leukot Essent Fatty Acids 1990;40:199-202.
112. Das UN, Prasad VVSK, Reddy DR: Local application of a gamma linolenic acid in the treatment of human gliomas. Cancer Lett 1995;94:147-155.
113. Fearon KCH, Falconer JS, Ross JA: An open I/II dose escalation study of the treatment of pancreatic cancer using lithium gamma-linolenate. Anticancer Res 1996;16:867-874.
114. Cai J, Jiang WG, Mansel RE: Inhibition of angiogenic factor-and tumour-induced angiogenesis by gamma-linolenic acid. Prostaglandins Leukot Essent Fatty Acids 1999;60: 21-29.
115. Jiang WG, Hiscox S, Horrobin DF, Bryce RP, Mansel RE: Gammalinolenic acid regulates expression of maspin and the motility of cancer cells. Biochem Biophys Res Commun 1997;237:639-644.
116. Prichard P, Brown G, Bhasker N, Hawkey C: The effect of dietary fatty acids on gastric production of prostaglandins and aspirin-induced injury. Aliment Pharmacol Ther 1988; 2:179-184.
117. Yoshimoto-Furuie K, Yoshimoto K, Tanaka T, Saima S, Kikuchi Y, Shay J, Horrobin DF, Hirotoshi E: Effects of oral supplementation with evening primrose oil for six weeks on plasma essential fatty acids and uremic skin symptoms in hemodialysis patients. Nephron 1999;81:151-159.
118. Tamimi NAM, Mikhail AI, Stevens PE: Role of γ-linolenic acid in uraemic patients. Nephron 1999;83:170-171.
119. Lawson LD, Hughes BG: Triacylglycerol structure of plant and fungal oils. Lipids 1988;23:313-317.